Because prior studies evaluating plasma biomarkers and HIV risk sampled cross-sectionally at various times prior to infection, it is likely that the heterogeneity in sample acquisition time contributed to somewhat conflicting findings between studies, including the variable directionality or lack of effect of IP-10 on HIV risk.4 The gene discussed is CXCL10; the disease is infection.